» Articles » PMID: 26005364

Is ESR Important for Predicting Post-ERCP Pancreatitis?

Overview
Publisher Sage Publications
Specialty Gastroenterology
Date 2015 May 26
PMID 26005364
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pancreatitis remains the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), resulting in substantial morbidity and occasional mortality. There are notable controversies and conflicting reports about risk factors of post-ERCP pancreatitis (PEP).

Aim: To evaluate the potential risk factors for PEP at a referral tertiary center, as a sample of the Iranian population.

Materials And Methods: Baseline characteristics and clinical as well as paraclinical information of 780 patients undergoing diagnostic and therapeutic ERCP at Taleghani hospital in Tehran between 2008 and 2012 were reviewed. Data were collected prior to the ERCP, at the time of the procedure, and 24-72 hours after discharge. PEP was diagnosed according to consensus criteria.

Results: Of the 780 patients who underwent diagnostic ERCP, pancreatitis developed in 26 patients (3.3%). In the multivariable risk model, significant risk factors with adjusted odds ratios (ORs) were age <65 years (OR = 10.647, P = 0.023) and erythrocyte sedimentation rate (ESR) >30 (OR = 6.414, P < 0.001). Female gender, history of recurrent pancreatitis, pre-ERCP hyperamylasemia, and difficult or failed cannulation could not predict PEP. There was no significant difference in the rate of PEP in wire-guided cannulation versus biliary cannulation using a sphincterotome and contrast injection as the conventional method.

Conclusions: Performing ERCP may be safer in the elderly. Patients with high ESR may be at greater risk of PEP, which warrants close observation of these patients for signs of pancreatitis after ERCP.

Citing Articles

Patient-related post-ERCP pancreatitis (PEP) risk factors between two groups of patients: Prophylactic pancreatic stent and rectal indomethacin.

Ghalehnoei H, Hormati A, Mohammad Alizadeh A, Ahmadpour S, Abedi S Caspian J Intern Med. 2022; 13(4):728-734.

PMID: 36420331 PMC: 9659831. DOI: 10.22088/cjim.13.4.728.


Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: What We Already Know.

Obeidat A, Mahfouz R, Monti G, Kozai L, Darweesh M, Mansour M Cureus. 2022; 14(1):e21773.

PMID: 35251843 PMC: 8890589. DOI: 10.7759/cureus.21773.

References
1.
Mallery J, Baron T, Dominitz J, Goldstein J, Hirota W, Jacobson B . Complications of ERCP. Gastrointest Endosc. 2003; 57(6):633-8. DOI: 10.1053/ge.2003.v57.amge030576633. View

2.
Kemppainen E, Hedstrom J, Puolakkainen P, Halttunen J, Sainio V, Haapiainen R . Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy. Gut. 1998; 41(5):690-5. PMC: 1891573. DOI: 10.1136/gut.41.5.690. View

3.
Cotton P, Garrow D, Gallagher J, Romagnuolo J . Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009; 70(1):80-8. DOI: 10.1016/j.gie.2008.10.039. View

4.
Christensen M, Matzen P, Schulze S, Rosenberg J . Complications of ERCP: a prospective study. Gastrointest Endosc. 2004; 60(5):721-31. DOI: 10.1016/s0016-5107(04)02169-8. View

5.
Gottlieb K, Sherman S . ERCP and biliary endoscopic sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am. 1998; 8(1):87-114. View